Join Michael Berry, MD and Lee Schwartzberg, MD from The University of Tennessee Health Science Center as they present their multidisciplinary expertise on a range of cases pertaining to hormone sensitive breast cancer.

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling and risk assessment and management for hereditary cancer syndromes.

The 2015 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of melanoma, biomarkers, management of cancer in older patients with comorbidities, managing symptoms and reducing complications, and two sessions on less common and complex canc

Background: Prescribing drugs outside of the label indication is legal and may reflect standard practice; however, some off-label use may be inappropriate.

The 2015 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of melanoma, biomarkers, management of cancer in older patients with comorbidities, managing symptoms and reducing complications, and two sessions on less common and complex canc

This information was originally presented as part of the NCCN 2015 Breast Cancer Congress Webinar Series.

This information was originally presented as part of the NCCN 2015 Breast Cancer Congress Webinar Series.

This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.

This information was originally presented as part of the NCCN 2015 Breast Cancer Congress Webinar Series.